Literature DB >> 6332578

Anti-hapten antibodies and autoantibodies in Japanese patients with lepromatous leprosy.

F Furukawa, G Ohshio, M Ozaki, Y Hamashima.   

Abstract

In the sera of patients with lepromatous leprosy anti-DNP antibodies were detected in order to determine the mode of polyclonal B-cell activation. Anti-DNP antibodies were found in 30% of the patients with active lepromatous leprosy and in 8% of those with inactive lepromatous leprosy. The level of anti-DNP antibodies in active patients was significantly higher than the level in inactive patients and control. However, the presence of anti-DNP antibodies was unrelated to the production of circulating immune complexes and antinuclear antibodies. These results suggest that polyclonal B-cell activation might occur but that the B-cell clones stimulated by M. leprae are different from patient to patient.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332578     DOI: 10.1007/bf00414019

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction.

Authors:  H N EISEN; M E CARSTEN; S BELMAN
Journal:  J Immunol       Date:  1954-11       Impact factor: 5.422

2.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

Authors:  S Izui; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Evidence for circulating immune complexes in lepromatous leprosy.

Authors:  C J Moran; G Ryder; J L Turk; M F Waters
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

5.  Autoantibodies in leprosy.

Authors:  C Masala; M A Amendolea; M Nuti; R Riccarducci; C G Tarabini; C G Tarabini
Journal:  Int J Lepr Other Mycobact Dis       Date:  1979-06

6.  Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy.

Authors:  F Furukawa; K Sekita; Y Hamashima; M Ozaki; S Imamura
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

7.  Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy.

Authors:  F Furukawa; M Ozaki; S Imamura; H Yoshida; A Pinrat; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Polyclonal B cell activation and autoimmunity in New Zealand mice. I. Natural thymocytotoxic autoantibody (NTA).

Authors:  S Hirose; N Maruyama; K Ohta; T Shirai
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

9.  A study of antispermatozoal antibodies in leprosy.

Authors:  S C Gupta; B Chhabra; T N Mehrotra; A K Bajaj
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-03

10.  Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

Authors:  W E Bullock; S Watson; K E Nelson; V Schauf; S Makonkawkeyoon; R R Jacobson
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

View more
  1 in total

1.  Possible polyclonal B cell activation in mucocutaneous lymph node syndrome.

Authors:  F Furukawa; G Ohshio; Y Hamashima
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.